Cathepsin B and Plasma Kallikrein Are Reliable Biomarkers to Discriminate Clinically Significant Hepatic Fibrosis in Patients with Chronic Hepatitis-C Infection

We aimed to determine the biomarker performance of the proteolytic enzymes cathepsin B (Cat B) and plasma kallikrein (PKa) and transforming growth factor (TGF)-β to detect hepatic fibrosis (HF) in chronic hepatitis C (CHC) patients. We studied 53 CHC patients and 71 healthy controls (HCs). Hepatic-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanelatto, Alexia de Cassia Oliveira, Lacerda, Gilmar de Souza, Accardo, Camila de Melo, do Rosário, Natalia Fonseca, da Silva, Andréa Alice, Motta, Guacyara, Tersariol, Ivarne Luis dos Santos, Xavier, Analucia Rampazzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501310/
https://www.ncbi.nlm.nih.gov/pubmed/36144371
http://dx.doi.org/10.3390/microorganisms10091769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501310/
https://www.ncbi.nlm.nih.gov/pubmed/36144371
http://dx.doi.org/10.3390/microorganisms10091769

Ejemplares similares